Home | About us | Editorial board | Ahead of print | Current issue | Archives | Search | Submit article | Instructions | Subscribe | Advertise | Contact us |  Login 
National Journal of Maxillofacial Surgery
 
Print this page Email this page Small font sizeDefault font sizeIncrease font size
Users Online: 158
 
This article has been cited by
1Management of macrocystic lymphatic malformation at uncommon site with aqueous bleomycin sclerotherapy
Ankur Bhatnagar,VijaiDatta Upadhyaya,Rajnikant Yadav,Basant Kumar
National Journal of Maxillofacial Surgery.2020;11(2)193
[DOI]
2Therapeutic effects of intralesional bleomycin sclerotherapy for non-invasive management of low flow vascular malformations - A prospective clinical study
Iram Jan,Ajaz Shah,ShahidHassan Beigh
Annals of Maxillofacial Surgery.2022;12(2)151
[DOI]
3Surgical management of vascular tumors and malformations of the head and neck in adults
Rachel A. Giese,Cristina Valero,Jatin P. Shah
Journal of Oral Pathology & Medicine.2022;51(10)854
[DOI]
4Percutaneous sclerotherapy of para-orbital and orbital venous malformation: A single center, case series
Saima Ahmad,Fahd Kamal Akhtar
Phlebology: The Journal of Venous Disease.2019;34(5)355
[DOI]
5Percutaneous sclerotherapy of para-orbital and orbital venous malformation: A single center, case series
René Müller-Wille,Walter A. Wohlgemuth
Phlebology: The Journal of Venous Disease.2021;34(5)175
[DOI]
6Intralesional therapies for vascular malformations of the head and neck
Vibhor Wadhwa,Bradley B. Pua,Angela V. Kadenhe-Chiweshe,Steven D. Rosenblatt
Journal of Oral Pathology & Medicine.2022;51(10)844
[DOI]
7Vitamin C increases DNA breaks and suppresses DNA damage-independent activation of ATM by bleomycin
Blazej Rubis,Michal W. Luczak,Casey Krawic,Anatoly Zhitkovich
Free Radical Biology and Medicine.2019;136(10)12
[DOI]
  Feedback 
  Subscribe 
  Reviewers